Introduction: health disparities and pharmaceutical advertising -- The pharmaceutical industry, direct to consumer advertising, and racial differences -- Direct to consumer advertising: patient empowerment or manipulation? -- Comparative analysis of the frequency and type of DTCA -- Differences in the appearance and content of DTCA -- Examination of the visual content of DTCA -- Conclusion: a missed opportunity: policy implications.